LBBW Aktienanleihe OMV 28.04.2025/ DE000LB46CP7 /
8/2/2024 9:07:54 AM | Chg.-0.52 | Bid5:20:42 PM | Ask5:20:42 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
97.30EUR | -0.53% | 96.66 Bid Size: 250,000 |
96.86 Ask Size: 250,000 |
OMV AG | 38.01 EUR | 4/28/2025 | Call |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
12/4/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center